Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Sep-24 7:38 PM View:  | Protagonist Therapeutics, Inc (PTGX) | 10-Sep-24 | Option Exercise | 8,000 | $12.88 | $103,040.00 | 67% 12.0K to 20.0K | |
| 12-Sep-24 7:38 PM View: | Protagonist Therapeutics, Inc (PTGX) | 10-Sep-24 | Planned Option Sale | 8,000 | $45.00 | $360,000.00 | (40%) 20.0K to 12.0K | |
| 26-Jul-24 4:31 PM View: | Protagonist Therapeutics, Inc (PTGX) | 24-Jul-24 | Option Exercise | 8,000 | $12.88 | $103,040.00 | 67% 12.0K to 20.0K | |
| 26-Jul-24 4:31 PM View: | Protagonist Therapeutics, Inc (PTGX) | 24-Jul-24 | Planned Option Sale | 8,000 | $40.00 | $320,000.00 | (40%) 20.0K to 12.0K | |
| 11-Jun-24 4:30 PM View: | Protagonist Therapeutics, Inc (PTGX) | 07-Jun-24 | Option Exercise | 8,000 | $12.88 | $103,040.00 | 67% 12.0K to 20.0K | |
| 11-Jun-24 4:30 PM View: | Protagonist Therapeutics, Inc (PTGX) | 07-Jun-24 | Planned Option Sale | 8,000 | $35.00 | $280,000.00 | (40%) 20.0K to 12.0K | |
| 01-Mar-24 8:45 PM View: | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Option Exercise | 12,975 | $6.09 | $79,017.80 | 108% 12.0K to 24.98K | |
| 01-Mar-24 8:45 PM View: | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Planned Option Sale | 12,975 | $31.34 | $406,636.00 | (52%) 24.98K to 12.0K | |
| 16-Jan-24 6:06 PM View: | Arrowhead Research Corp. (ARWR) | 11-Jan-24 | Sale (Planned) | 3,934 | $38.07 | $149,759.00 | (8%) 51.8K to 47.87K | |
| 19-Dec-23 3:41 PM View: | Arrowhead Research Corp. (ARWR) | 15-Dec-23 | Grant | 14,987 | $25.41 | $380,820.00 | 41% 36.82K to 51.8K | |
| 11-Jan-23 8:23 PM View: | Arrowhead Research Corp. (ARWR) | 10-Jan-23 | Grant | 7,867 | -- | -- | 27% 28.95K to 36.82K | |
| 11-Jan-23 8:23 PM View: | Arrowhead Research Corp. (ARWR) | 09-Jan-23 | Sale (Planned) | 3,200 | $30.00 | $96,000.00 | (10%) 32.15K to 28.95K | |
| 04-May-22 8:41 PM View: | Protagonist Therapeutics, Inc (PTGX) | 03-May-22 | Option Exercise | 12,000 | $8.59 | $103,080.00 | 100% 0 to 12.0K | |
| 07-Jan-22 8:14 PM View: | Arrowhead Research Corp. (ARWR) | 07-Jan-22 | Grant | 6,400 | -- | -- | 25% 25.75K to 32.15K | |
| 04-Jan-22 10:00 PM View: | Arrowhead Research Corp. (ARWR) | 03-Jan-22 | Market Sale (Planned) | 4,500 | $64.72 | $291,244.00 | (15%) 30.25K to 25.75K | (8%) |
| 05-Jan-21 6:01 PM View: | Arrowhead Research Corp. (ARWR) | 04-Jan-21 | Market Sale | 3,750 | $76.08 | $285,300.00 | (11%) 34.0K to 30.25K | |
| 05-Jan-21 6:01 PM View: | Arrowhead Research Corp. (ARWR) | 01-Jan-21 | Grant | 9,000 | -- | -- | 36% 25.0K to 34.0K | |
| 11-Dec-20 6:16 PM View: | Arrowhead Research Corp. (ARWR) | 10-Dec-20 | Market Sale | 3,000 | $71.26 | $213,780.00 | (11%) 28.0K to 25.0K | |
| 13-May-20 6:45 PM View: | Arrowhead Research Corp. (ARWR) | 11-May-20 | Market Sale | 26,000 | $36.54 | $950,040.00 | (48%) 54.0K to 28.0K | |
| 03-Jan-20 6:06 PM View: | Arrowhead Research Corp. (ARWR) | 01-Jan-20 | Grant | 7,500 | -- | -- | 16% 46.5K to 54.0K | |
| 11-Jan-19 6:15 PM View: | Arrowhead Research Corp. (ARWR) | 11-Jan-19 | Market Sale | 8,500 | $14.77 | $125,545.00 | (15%) 55.0K to 46.5K | (2%) |
| 03-Jan-19 8:18 PM View: | Arrowhead Research Corp. (ARWR) | 01-Jan-19 | Grant | 30,000 | -- | -- | 120% 25.0K to 55.0K | |
| 03-Jan-18 7:46 PM View: | Arrowhead Research Corp. (ARWR) | 01-Jan-18 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 03-Oct-16 9:41 PM View: | Calithera Biosciences, Inc. (CALA) | 29-Sep-16 | Disposition (other) | 17,485 | -- | -- | (50%) 34.97K to 17.48K | |
| 16-Jul-15 5:41 PM View: | Calithera Biosciences, Inc. (CALA) | 14-Jul-15 | Option Exercise | 13,125 | $2.64 | $34,650.00 | 70% 18.67K to 31.8K | |
| 18-Dec-14 5:19 PM View: | Calithera Biosciences, Inc. (CALA) | 16-Dec-14 | Option Exercise | 6,797 | $3.43 | $23,283.80 | 73% 9.38K to 16.17K | |
| 23-Jul-13 7:06 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 23-Jul-13 | Conversion | 5,159 | -- | -- | 21% 24.6K to 29.76K |